- Myeloid leukemia after hematotoxins. Larson, Richard A.; LeBeau, Michelle M. // Environmental Health Perspectives Supplements;Dec96 Supplement 6, Vol. 104, p1303
Investigates myeloid leukemia after hematotoxins. Mutations and leukemogenesis; Prior therapy, latency period and clinical features of therapy-related myeloid leukemia; Role of 11q23 translocations; Cytogenetic abnormalities in therapy-related myeloid leukemia.
- Chronic myeloid leukaemia. Goldman, John // BMJ: British Medical Journal (International Edition);03/01/97, Vol. 314 Issue 7081, p657
Focuses on chronic myeloid leukemia. Clinical features; Survival from date of diagnosis; Chronic phase disease; Peripheral blood findings; Recommendation of cryopreservation of semen to young men; Treatment.
- Heritage of a Philadelphia chromosome. R.M.D. // Cortlandt Forum;5/25/96, Vol. 9 Issue 5, p58
Reports on how one acquires a Philadelphia chromosome, a characteristic feature of chronic myelogenous leukemia. Result of reciprocal translocation between the long arms of chromosomes nine and 22.
- Characterization of a recurrent translocation t(2;3)(p15â€“22;q26) occurring in acute myeloid leukemia. Trubia, M.; Albano, F.; Cavazzini, F.; Cambrin, G. R.; Quarta, G.; Fabbiano, F.; Ciambelli, F.; Magro, D.; Hernandez, J. M.; Mancini, M.; Diverio, D.; Pelicci, P. G.; Coco, F. L.; Mecucci, C.; Specchia, G.; Rocchi, M.; Liso, V.; Castoldi, G.; Cuneo, A. // Leukemia (08876924);Jun2006, Vol. 20 Issue 6, p1195
A correction to the article "Characterization of a Recurrent Translocation t(2;3)(p15â€“22;q26) Occurring in Acute Myeloid Leukemia," that was published in the previous issues of the journal is presented.
- Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML. Falini, B; Bigerna, B; Pucciarini, A; Tiacci, E; Mecucci, C; Morris, S.W.; Bolli, N; Rosati, R; Hanissian, S; Ma, Z; Sun, Y; Colombo, E; Arber, D.A.; Pacini, R; La Starza, R; Galletti, B.V.; Liso, A; Martelli, M.P.; Diverio, D; Pelicci, P.-G. // Leukemia (08876924);Jul2006, Vol. 20 Issue 7, p1330
A correction to the article "Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukemia carrying t(3;5): A comparison with NPMc+AML" that appeared in the march 9, 2006 issue of the journal "Leukemia" is presented.
- Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment. Chou, W-C; Tang, J-L; Yao, M; Liang, Y-J; Lee, F-Y; Lin, M-T; Wang, C-H; Shen, M-C; Chen, Y-C; Tien, H-F // Leukemia (08876924);Jul97, Vol. 11 Issue 7, p921
Acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) and chemotherapy have been shown to have better outcome than those treated with conventional chemotherapy alone. However, the biological characteristics of leukemic cells and their clinical implications in...
- Facial Nerve Paralysis and Paraplegia as Presenting Symptoms of Acute Myeloid Leukemia. Eser, Bulent; Cetin, Mustafa; Kontas, Olgun; Unal, Ali; Er, Ozlem; Coskun, Hasan Senol; Altinbas, Mustafa // Japanese Journal of Clinical Oncology;Feb2001, Vol. 31 Issue 2, p86
Discusses the facial nerve paralysis and paraplegia as presenting symptoms of acute myeloid leukemia (AML). Medical case of granulocytic sarcoma (GS), a localized tumor composed of immature cells of the granulocytic series; Association of GS with AML; Differences in histopathological appearance...
- Reduced-Intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife? Gale, R P // Leukemia (08876924);Jul2015, Vol. 29 Issue 7, p1448
An introduction is presented in which the editor discusses reports within the issue including data from the acute myeloid leukemia (AML)15 trial of Medical Research Council (MRC), and emergence of reduced-intensity conditioning (RIC) allotransplants as a way to decrease non-relapse mortality (NRM).
- A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4). Bernasconi, P; Cavigliano, P M; Boni, M; Malcovati, L; Calatroni, S; Astori, C; Caresana, M; Bernasconi, C // Leukemia (08876924);Mar99, Vol. 13 Issue 3, p487
Reports on noval t(Y;11) translocations with multiple myelocytic leukemia gene arrangement in a case of acute myelomonocytic leukemia. Problems faced by the patient related to bone pain; Blood analysis of the patient; Several tests conducted on the patient; Patient's response to the treatment.